PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The goal of this study is to investigate the feasibility and toxicity of using prostate-specific membrane antigen-positron emission tomography (PSMA-PET) and multi-parametric magnetic resonance imagining (mpMRI) with PET-MR technology to define radiotherapy targets, while meeting all the current planning criteria.
Epistemonikos ID: 3e0d97b88079de3bd1b11f932f9e8ca9553ab670
First added on: May 06, 2024